PLoS Medicine
: free full text online articles

Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies
Johnson LF et al.
This study estimates 80% of normal life expectancy for HIV positive South African adults who start ARVS while their CD4 count is still 200 or higher by using information from 6 programmes between 2001 and 2010.

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies
Gomez GB et al.

Preventing antiretroviral treatment interruptions among HIV/AIDS patients in Africa
Mills EJ and Nabiryo C.
Norma Ware and colleagues conducted a large qualitative study among patients in HIV treatment programs in sub-Saharan Africa to investigate reasons for missed visits and provide an explanation for disengagement from care.

Links to other websites are current at date of posting but not maintained.